Profile data is unavailable for this security.
About the company
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
- Revenue in JPY (TTM)2.05tn
- Net income in JPY304.60bn
- Incorporated2005
- Employees19.77k
- LocationDaiichi Sankyo Co LtdDaiichi Sankyo Bldg. A/B Kan3-5-1, Nihombashi Hon-choCHUO-KU 103-8426JapanJPN
- Phone+81 362251111
- Websitehttps://www.daiichisankyo.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ono Pharmaceutical Co Ltd | 509.35bn | 62.40bn | 1.25tn | 4.29k | 18.87 | 1.40 | 12.57 | 2.45 | 132.76 | 132.76 | 1,084.01 | 1,786.88 | 0.4702 | 2.14 | 3.38 | 118,811,500.00 | 5.77 | 10.78 | 6.61 | 12.37 | 69.79 | 73.23 | 12.27 | 21.23 | 2.56 | 125.26 | 0.1283 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
| Kyowa Kirin Co Ltd | 496.83bn | 67.04bn | 1.35tn | 5.67k | 20.06 | 1.51 | 14.49 | 2.72 | 128.07 | 128.07 | 949.13 | 1,706.50 | 0.4568 | 1.82 | 2.99 | -- | 6.16 | 6.40 | 7.33 | 7.37 | 74.25 | 74.99 | 13.49 | 14.37 | 2.35 | -- | -- | 46.19 | 0.2559 | 9.31 | 11.98 | 7.35 | 19.80 | 7.10 |
| Eisai Co Ltd | 808.19bn | 42.76bn | 1.45tn | 13.51k | 32.70 | 1.57 | 17.28 | 1.79 | 151.67 | 151.67 | 2,866.61 | 3,153.46 | 0.5537 | 0.7996 | 3.33 | 59,839,040.00 | 3.04 | 3.81 | 4.22 | 5.14 | 77.75 | 77.47 | 5.48 | 6.44 | 1.54 | -- | 0.2015 | 98.01 | 6.42 | 2.56 | 9.49 | -17.54 | -14.48 | 0.00 |
| Shionogi & Co Ltd | 465.35bn | 194.86bn | 3.14tn | 4.96k | 15.44 | 1.99 | 14.57 | 6.76 | 228.94 | 228.94 | 546.70 | 1,779.33 | 0.2869 | 0.8648 | 2.76 | 93,915,640.00 | 11.98 | 12.17 | 13.13 | 13.74 | 84.50 | 84.91 | 41.78 | 38.30 | 5.21 | -- | 0.0148 | 27.87 | 0.7325 | 5.62 | 5.19 | 6.88 | 34.66 | 12.30 |
| Astellas Pharma Inc | 2.06tn | 322.91bn | 4.47tn | 13.64k | 13.76 | 2.51 | 8.68 | 2.17 | 179.57 | 179.57 | 1,145.43 | 984.21 | 0.5841 | 1.27 | 2.90 | 151,038,200.00 | 9.15 | 3.05 | 14.11 | 4.45 | 81.00 | 81.15 | 15.67 | 5.42 | 0.839 | 41.32 | 0.2913 | 131.42 | 19.25 | 8.01 | 197.72 | -23.64 | -5.94 | 13.09 |
| Otsuka Holdings Co Ltd | 2.42tn | 449.11bn | 5.36tn | 35.34k | 11.71 | 1.82 | 9.49 | 2.22 | 842.65 | 842.65 | 4,540.85 | 5,413.66 | 0.64 | 2.11 | 4.86 | 68,439,860.00 | 12.01 | 5.91 | 15.12 | 7.27 | 71.72 | 69.18 | 18.76 | 9.89 | 1.65 | -- | 0.0695 | 32.93 | 15.42 | 10.78 | 182.13 | 21.96 | 15.32 | 3.71 |
| Daiichi Sankyo Co Ltd | 2.05tn | 304.60bn | 5.50tn | 19.77k | 17.76 | 3.14 | 14.54 | 2.68 | 163.62 | 163.62 | 1,103.05 | 924.09 | 0.5649 | 0.8183 | 3.11 | 103,827,400.00 | 8.38 | 5.72 | 10.55 | 7.11 | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | 49.57 | 17.77 | 13.95 | 44.47 | 17.77 | 29.01 | 20.79 |
| Takeda Pharmaceutical Co Ltd | 4.46tn | 112.93bn | 8.92tn | 47.46k | 77.62 | 1.16 | 10.37 | 2.00 | 72.26 | 72.26 | 2,834.46 | 4,838.54 | 0.2926 | 1.17 | 6.17 | 94,080,250.00 | 0.7418 | 1.71 | 0.8772 | 2.04 | 65.33 | 67.66 | 2.54 | 5.99 | 0.6548 | 3.49 | 0.3884 | 123.75 | 7.45 | 6.84 | -25.08 | 19.53 | 9.82 | 1.72 |
| Chugai Pharmaceutical Co Ltd | 1.26tn | 434.01bn | 15.45tn | 7.78k | 34.88 | 7.47 | -- | 12.28 | 263.73 | 263.73 | 764.40 | 1,230.91 | 0.5379 | 1.41 | 3.59 | -- | 18.56 | 19.40 | 21.83 | 23.54 | 71.09 | 66.75 | 34.50 | 31.46 | 3.56 | 583.66 | -- | 40.95 | 7.46 | 9.84 | 12.06 | 15.11 | 12.69 | 17.27 |
Data as of Feb 13 2026. Currency figures normalised to Daiichi Sankyo Co Ltd's reporting currency: Japanese Yen JPY
31.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 15 Jan 2026 | 100.13m | 5.29% |
| Nomura Asset Management Co., Ltd.as of 08 Jan 2026 | 93.48m | 4.94% |
| Capital International Ltd.as of 08 Jan 2026 | 73.56m | 3.88% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 66.74m | 3.52% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 57.52m | 3.04% |
| Asset Management One Co., Ltd.as of 29 Aug 2025 | 56.11m | 2.96% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 44.02m | 2.32% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2025 | 41.63m | 2.20% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 38.12m | 2.01% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 33.46m | 1.77% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
